These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18431552)

  • 41. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules.
    Cengiz M; Ozyar E; Esassolak M; Altun M; Akmansu M; Sen M; Uzel O; Yavuz A; Dalmaz G; Uzal C; Hiçsönmez A; Sarihan S; Kaplan B; Atasoy BM; Ulutin C; Abacioğlu U; Demiral AN; Hayran M
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1347-53. PubMed ID: 16169671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relationship between global and specific components of quality of life, assessed with the EORTC QLQ-C30 in a sample of 2019 cancer patients.
    Hinz A; Mehnert A; Dégi C; Reissmann DR; Schotte D; Schulte T
    Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26568527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality of life in gastric cancer.
    Kaptein AA; Morita S; Sakamoto J
    World J Gastroenterol; 2005 Jun; 11(21):3189-96. PubMed ID: 15929166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy.
    Allal AS; Sprangers MA; Laurencet F; Reymond MA; Kurtz JM
    Br J Cancer; 1999 Jul; 80(10):1588-94. PubMed ID: 10408404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of quality of life with disease characteristics and treatment outcomes in patients with advanced gastric cancer: Exploratory analysis of RAINBOW and REGARD phase III trials.
    Chau I; Fuchs CS; Ohtsu A; Barzi A; Liepa AM; Cui ZL; Hsu Y; Al-Batran SE
    Eur J Cancer; 2019 Jan; 107():115-123. PubMed ID: 30557792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment Strategies and Prognostic Factors of Primary Gastric Diffuse Large B Cell Lymphoma: A Retrospective Multicenter Study of 272 Cases from the China Lymphoma Patient Registry.
    Yang H; Wu M; Shen Y; Lei T; Mi L; Leng X; Ping L; Xie Y; Song Y; Cen X; Zhu J
    Int J Med Sci; 2019; 16(7):1023-1031. PubMed ID: 31341416
    [No Abstract]   [Full Text] [Related]  

  • 47. Quality of life after total and subtotal gastrectomy for gastric carcinoma.
    Goh YM; Gillespie C; Couper G; Paterson-Brown S
    Surgeon; 2015 Oct; 13(5):267-70. PubMed ID: 25127442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of the polish version of the eortc QLQ-C30 and the QLQ-OG25 for the assessment of health-related quality of life in patients with esophagi-gastric cancer.
    Tomaszewski KA; Püsküllüoğlu M; Biesiada K; Bochenek J; Nieckula J; Krzemieniecki K
    J Psychosoc Oncol; 2013; 31(2):191-203. PubMed ID: 23514254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quality of life after total or partial gastrectomy for primary gastric lymphoma.
    Hjermstad MJ; Hollender A; Warloe T; Karlsen KO; Ikonomo I; Kvaloy S; Nome O; Holte H
    Acta Oncol; 2006; 45(2):202-9. PubMed ID: 16546867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different clinical characteristics and treatment strategies for patients with localized sinonasal diffuse large B cell lymphoma and extranodal NK/T cell lymphoma.
    Huang Y; Jia B; Jiang S; Zhou S; Yang J; Liu P; Gui L; He X; Qin Y; Sun Y; Shi Y
    J Hematol Oncol; 2017 Jan; 10(1):7. PubMed ID: 28057019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical characteristics and treatment strategies for early-stage primary gastric diffuse large B-cell lymphoma].
    Qin Y; Liu P; Yang JL; Jin J; He XH; Wang WH; Fang H; Zhou SY; Zhou LQ; Song YW; Shi YK
    Zhonghua Yi Xue Za Zhi; 2018 Jun; 98(24):1945-1950. PubMed ID: 29996288
    [No Abstract]   [Full Text] [Related]  

  • 52. Primary gastric diffuse large B-cell lymphoma.
    Hung YS; Lin TL; Kuo MC; Tang TC; Dunn P; Wang PN; Wu JH; Chang H; Kuo TT; Shih LY
    Chang Gung Med J; 2008; 31(2):159-66. PubMed ID: 18567416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Survival Benefit with Consolidative Radiotherapy in Early-Stage Diffuse Large B‑Cell Lymphoma patients].
    Elsayad K; Eich HT
    Strahlenther Onkol; 2016 Jul; 192(7):502-4. PubMed ID: 27245817
    [No Abstract]   [Full Text] [Related]  

  • 54. Quality of life for patients with esophageal/gastric cardia precursor lesions or cancer: a one-year prospective study.
    Wen Y; Pan XF; Huang WZ; Zhao ZM; Wei WQ; Chen F; Lan H; Huang H; Yang CX; Qiao YL
    Asian Pac J Cancer Prev; 2015; 16(1):45-51. PubMed ID: 25640389
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic effect of Jinlongshe Granule () on quality of life of stage IV gastric cancer patients using EORTC QLQ-C30: A double-blind placebo-controlled clinical trial.
    Sun DZ; Jiao JP; Zhang X; Xu JY; Ye M; Xiu LJ; Zhao Y; Lu Y; Liu X; Zhao J; Shi J; Qin ZF; Wei PK
    Chin J Integr Med; 2015 Aug; 21(8):579-86. PubMed ID: 25399306
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quality of Life in NSCLC Survivors - A Multicenter Cross-Sectional Study.
    Hechtner M; Eichler M; Wehler B; Buhl R; Sebastian M; Stratmann J; Schmidberger H; Gohrbandt B; Peuser J; Kortsik C; Nestle U; Wiesemann S; Wirtz H; Wehler T; Bals R; Blettner M; Singer S
    J Thorac Oncol; 2019 Mar; 14(3):420-435. PubMed ID: 30508641
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bcl-6 expression and lactate dehydrogenase level predict prognosis of primary gastric diffuse large B-cell lymphoma.
    Chung KM; Chang ST; Huang WT; Lu CL; Wu HC; Hwang WS; Chang KY; Chuang SS
    J Formos Med Assoc; 2013 Jul; 112(7):382-9. PubMed ID: 23927977
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serial intermediate-term quality of life comparison after endoscopic submucosal dissection versus surgery in early gastric cancer patients.
    Kim YI; Kim YA; Kim CG; Ryu KW; Kim YW; Sim JA; Yun YH; Choi IJ
    Surg Endosc; 2018 Apr; 32(4):2114-2122. PubMed ID: 29067581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does gastric adenocarcinoma develop after the treatment of gastric lymphoma?
    Zorlu AF; Atahan IL; Gedikoglu G; Ruacan S; Sayek I; Tekuzman G
    J Surg Oncol; 1993 Oct; 54(2):126-31. PubMed ID: 8412159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan.
    Tanaka T; Shimada K; Yamamoto K; Hirooka Y; Niwa Y; Sugiura I; Kitamura K; Kosugi H; Kinoshita T; Goto H; Nakamura S
    Ann Hematol; 2012 Mar; 91(3):383-90. PubMed ID: 21822617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.